-
Product Insights
New![]()
Net Present Value Model: Innate Pharma SA’s Monalizumab
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Innate Pharma SA’s Lacutamab
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Company Insights
New![]()
Innovation and Patenting activity of Innate Pharma SA Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Innate Pharma SA Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Recombinant Plasma Gelsolin Replacement For Neuroinflammation in Neuroinflammation
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Recombinant Plasma Gelsolin Replacement For Neuroinflammation in NeuroinflammationDrug Details:Recombinant plasma gelsolin (pGSN) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Recombinant Plasma Gelsolin Replacement For Arthritis, Inflammation, Trauma And Burns in Burns
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Recombinant Plasma Gelsolin Replacement For Arthritis, Inflammation, Trauma And Burns in Burns Drug Details:Recombinant plasma gelsolin...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Recombinant Plasma Gelsolin Replacement For Cystic Fibrosis And Bronchiectasis in Bronchiectasis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Recombinant Plasma Gelsolin Replacement For Cystic Fibrosis And Bronchiectasis in Bronchiectasis Drug Details:Recombinant plasma gelsolin (pGSN)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Recombinant Plasma Gelsolin Replacement for Infectious Disease in Sepsis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Recombinant Plasma Gelsolin Replacement for Infectious Disease in Sepsis Drug Details: Recombinant plasma gelsolin (pGSN)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Recombinant Plasma Gelsolin Replacement For Arthritis, Inflammation, Trauma And Burns in Trauma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Recombinant Plasma Gelsolin Replacement For Arthritis, Inflammation, Trauma And Burns in TraumaDrug Details:Recombinant plasma gelsolin is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Recombinant Plasma Gelsolin Replacement For Infectious Disease in Acute Lung Injury
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Recombinant Plasma Gelsolin Replacement For Infectious Disease in Acute Lung Injury Drug Details: Recombinant plasma...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cibinetide in Diabetic Macular Edema
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cibinetide in Diabetic Macular Edema Drug Details: Cibinetide is under development for the treatment...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.